BioSpace News Archive

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body’s immune system in the fight against cancer, today announced that data related to Anixa’s recently launched Cchek™ Prostate Cancer Confirmation test (Cchek™ PCC) will be presented at the “AI and Big Data in Cancer: From Innovation to Impact” conference

Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), is pleased to announce today the appointment of Scott Antony as Senior Vice President of U.S. Retail Sales.

Oxford Immunotec Global PLC (Nasdaq: OXFD), or the Company, a global, high-growth diagnostics company, today announced fourth quarter and full year 2019 financial results.

$10 Million Gift from the Pincus Family Foundation Advances Children’s Health Worldwide

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, will report fourth quarter and 2019 financial results following the close of U.S. financial markets on Mar. 18 and host a conference call at 1:30 p.m. PT/4:30 p.m. ET to discuss the results and provide operational updates.

Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity, today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2019.

Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced the appointment of Alexander Kolevzon, M.D., a leader in child and adolescent psychiatry, to its Scientific Advisory Board (SAB).

Dynavax is providing CpG 1018, the adjuvant contained in HEPLISAV-B, to support the rapid development of a COVID-19 vaccine

Boston Biomedical, Inc. announced today that its parent company, Sumitomo Dainippon Pharma Co., Ltd. (Osaka, Japan) has invested in the MPM Oncology Innovations Fund (hereinafter, “INV”), and made a donation to the Dana-Farber Innovations Research Fund (hereinafter, “IRF”).

Agragene, Inc., a sustainable agricultural technology company developing novel biological crop pest protection products, announced today that it has raised $1.2 million in a seed financing round.